Characteristics and Outcome of AIDS-Related Hodgkin Lymphoma Before and After the Introduction of Highly Active Antiretroviral Therapy

OBJECTIVES:We analyzed survival, therapeutic response, and prognostic factors in patients with HIV-related Hodgkin lymphoma (HL) treated or not with highly active antiretroviral therapy (HAART). METHODS:This study included 104 patients with HL, treated (n = 83) or not (n = 21) with HAART. Outcomes a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of acquired immune deficiency syndromes (1999) 2008-04, Vol.47 (4), p.422-428
Hauptverfasser: Berenguer, Juan, Miralles, Pilar, Ribera, José María, Rubio, Rafael, Valencia, Eulalia, Mahillo, Beatriz, Pintado, Vicente, Palacios, Rosario, Montes, María Luisa, Téllez, María Jesús, La Cruz, José, Torre-Cisneros, Julián, Rodríguez-Arrondo, Francisco, Sepúlveda, María Antonia, Gutiérrez, Félix, Peralta, Galo, Boix, Vicente
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:OBJECTIVES:We analyzed survival, therapeutic response, and prognostic factors in patients with HIV-related Hodgkin lymphoma (HL) treated or not with highly active antiretroviral therapy (HAART). METHODS:This study included 104 patients with HL, treated (n = 83) or not (n = 21) with HAART. Outcomes and prognostic factors of complete remission (CR), overall survival (OS), and disease-free survival (DFS) were assessed by an intention-to-treat analysis of all patients who received at least 1 chemotherapy course. RESULTS:No differences were found between groups at baseline in the specific characteristics of HIV and HL. The proportion of patients receiving appropriate-for-stage therapy for HL was similar for both groups. The CR rates in the HAART (−) and HAART (+) groups were 14 (70%) of 20 versus 71 (91%) of 78 (P = 0.023). The median OS in the HAART (−) group was 39 months (95% confidence interval [CI]0 to 89) and was not reached in the HAART (+) group (P = 0.0089). The median DFS in the HAART (−) group was 85 months (95% CI73 to 97) and was not reached in the HAART (+) group (P = 0.129). Factors independently associated with CR by logistic regression analysis were appropriate-for-stage therapy of HL, HAART, and baseline CD4 count ≥100 cells/μL. CR was the only factor independently associated with OS by Cox regression analysis. CONCLUSIONS:The achievement of CR was independently associated with appropriate-for-stage therapy for HL, with HAART, and with a baseline CD4 count ≥100 cells/μL. The only variable independently associated with OS was the achievement of CR.
ISSN:1525-4135
1944-7884
DOI:10.1097/QAI.0b013e31815e722b